PET/CT > Indications


Indications for PET imaging with FDG

  1. Breast cancer: staging of distant metastasis, restaging, and monitoring response to treatment (when a change in therapy is anticipated based on results)
  2. Cervical cancer: staging as adjunct to conventional imaging
  3. Colorectal cancer: diagnosis, staging, and restaging
  4. Esophageal cancer: diagnosis, staging, and restaging
  5. Head and neck cancer (non-thyroid, non-CNS): diagnosis, staging, and restaging
  6. Lymphoma: diagnosis, staging, and restaging
  7. Melanoma: diagnosis, staging, and restaging
  8. Non small cell lung cancer: diagnosis, staging, and restaging
  9. Solitary pulmonary nodules: characterization
  10. Follicular cell thyroid cancer: restaging of recurrent or residual disease previously treated by thyroidectomy and radioiodine ablation in the setting of serum thyroglobulin > 10 ng/ml and a negative I-131 whole body scan
  11. Myocardial viability: primary or initial diagnosis or following an inconclusive SPECT prior to revascularization
  12. Refractory seizures (brain): pre-surgical evaluation only